✦ LIBER ✦

Prognostic relavance of cerbB2 expression following neoadjuvant chemotherapy in patients in a randomised trial of neoadjuvant versus adjuvant chemoendocrine therapy

✍ Scribed by R.K. Gregory; T.J. Powles; J. Salter; J.C. Chang; S. Ashley; M. Dowsett

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Neoadjuvant chemotherapy with trastuzuma

✍ Luca Gianni; Wolfgang Eiermann; Vladimir Semiglazov; Alexey Manikhas; Ana Lluch; 📂 Article 📅 2010 🏛 The Lancet 🌐 English ⚖ 124 KB

Biweekly docetaxel and gemcitabine as ne

✍ L. G. Estévez; P. Sánchez-Rovira; M. Dómine; A. León; I. Calvo; A. Jaén; V. Casa 📂 Article 📅 2007 🏛 Springer Milan 🌐 Spanish ⚖ 80 KB

Treatment with trastuzumab for 1 year af

✍ Luca Gianni; Urania Dafni; Richard D Gelber; Evandro Azambuja; Susanne Muehlbaue 📂 Article 📅 2011 🏛 The Lancet 🌐 English ⚖ 322 KB

Final results and pharmacoeconomic analy

✍ Berghmans, T.; Lafitte, J.J.; Giner, V.; Berchier, M.C.; Scherpereel, A.; Lewin, 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 337 KB

A randomised controlled trial of pre-ope

✍ Stephens, Richard J.; Girling, David J.; Hopwood, Penelope; Thatcher, Nicholas 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 85 KB